Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus
NCT ID: NCT05637385
Last Updated: 2022-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2023-03-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Moderators and Mediators of Perceptual Learning
NCT05894967
Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss
NCT06670989
Eye Movements, Visual Perception and Attention
NCT03884985
Effect of Visual Retraining After Stroke
NCT06121219
Visual Rehabilitation After Occipital Stroke
NCT04798924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A single-site, two-way mixed factor, one within-subject and one between-subject, minimal-risk phase-2 study. Each participant with vision loss or in the control group will attend for three outcome-measurement visits and 16 training visits over a period of about two months (at 2 visits per week). Feasibility metrics will be obtained during recruitment and study conduct. PRL and OMC metrics will be obtained at every visit. Outcome metrics will be obtained before treatment, following 8 training sessions, and following 16 training sessions.
Participants in the control group will experience a simulated central scotoma created by a gaze-contingent visual display system that simulates the loss of central vision by obscuring a region of central vision during testing and training.
Participants will be trained using an integrated oculo-motor and perceptual training approach using a gaze-contingent visual display to provide scotoma awareness. Two tasks will alternate: (1) a textured search target that suddenly shifts, drifts smoothly, or is stable, requiring the subject to make a saccade, a smooth pursuit, or fixate, respectively, following which there is a same-different task to test attention; and (2) target following and visual search for (a) face within distractors, (b) object recognition and location, and (c) word recognition and object identification over cluttered background. During training, for the vision-loss group, the binocular scotoma (created by the retinal lesions) will be outlined using a gaze-contingent system, so that the subject will see a border at the edge of their binocular scotoma that moves with gaze, alerting them to the location of the scotoma.
In addition to the 16 training sessions, there will be longer (2.5 to 3 hours) measurement sessions: (1) before training; (2) after 8 training sessions; and (3) after 16 training sessions. Due to the number of procedures, the first measurement session might consist of two sessions. Thus, each participant with vision loss will participate in 19 or 20 sessions in total.
Ideally, participants will attend for two visits per week. However, the schedule is flexible and can be adapted to a participants schedule.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
central vision loss
will receive behavioral intervention
Training of perception and oculo-motor control
Behavioral training of eye movements and perception
normal vision
using simulated central scotomas, will receive behavioral intervention
Training of perception and oculo-motor control
Behavioral training of eye movements and perception
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training of perception and oculo-motor control
Behavioral training of eye movements and perception
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fluent in English
* Cognitive function MoCA (Montreal Cognitive Assessment) test \>20
* Binocular visual acuity 20/800 or better
* able to sit for at least an hour
* fluent in English
* Cognitive function MoCA (Montreal Cognitive Assessment) test \>25
* Binocular visual acuity 20/40 or better
* able to sit for at least an hour
Exclusion Criteria
* history of neurological or psychiatric disease
* inability to provide informed consent
* inability to follow instructions in English
Normal Vision Control Group
* any ophthalmic disease that might impact on the conduct of the study, especially conditions that cause vision field loss
* speech impediment
* history of neurological or psychiatric disease
* inability to provide informed consent
* inability to follow instructions in English
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research to Prevent Blindness / Lions Club International Foundation
UNKNOWN
Russell L. Woods
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Russell L. Woods
Associate Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Russell L Woods, PhD
Role: PRINCIPAL_INVESTIGATOR
Schepens Eye Research Institute
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022P002309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.